|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.53 CNY | -6.37% |
|
-2.22% | -54.39% |
| 05-08 | Yichang HEC Still Negotiating Merger Deal with Sunshine Lake Pharma | MT |
| 04-29 | Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Changjiang Pharmaceutical Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 59.09 million compared to CNY 136.79 million a year ago. Net loss was CNY 47.51 million compared to CNY 22.96 million a year ago.
Basic loss per share from continuing operations was CNY 0.1356 compared to CNY 0.0655 a year ago. Diluted loss per share from continuing operations was CNY 0.1356 compared to CNY 0.0655 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -54.39% | 183M | |
| +34.35% | 693B | |
| +29.39% | 584B | |
| -3.49% | 372B | |
| +20.15% | 332B | |
| +6.19% | 294B | |
| +14.11% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +9.21% | 168B |
CHANGJIANG PHARMACEUTICAL GROUP CO., LTD. 
